K Woelkart

1.3k citations
17 papers · 873 indexed · h-index 14
Topics
Herbal Medicine Research Studies (14 papers)Toxin Mechanisms and Immunotoxins (8 papers)Complementary and Alternative Medicine Studies (6 papers)

In The Last Decade

K Woelkart

17 papers receiving 814 citations

Peers

K Woelkart
Comparison fields: 5 of 76
  • Complementary and alternative medicine 669
  • Immunology 279
  • Pharmacology 134
  • Plant Science 126
  • Molecular Biology 114
Replace Andy Suter with:
Andy Suter Switzerland
John F. Livesey Canada
Sudipta Chanda India
Azam Alavinezhad Iran
Sung‐Ki Jung South Korea
J S Stern United States
Marco Miroddi Italy
Dongyu Ge China
Laura Bordoni Italy
Jen Woods United States
K Woelkart relative to Andy Suter Switzerland Andy Suter's profile →
Citations per field
00.5×1.5×1.8×
Andy Suter · 1×
Citations per year

Countries citing papers authored by K Woelkart

Since Specialization
Citations

This map shows the geographic impact of K Woelkart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Woelkart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Woelkart more than expected).

Fields of papers citing papers by K Woelkart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Woelkart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Woelkart. The network helps show where K Woelkart may publish in the future.

Co-authorship network of co-authors of K Woelkart

This figure shows the co-authorship network connecting the top 25 collaborators of K Woelkart. A scholar is included among the top collaborators of K Woelkart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Woelkart. K Woelkart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 55
2 15
3 34
4 149
5 17
6 38
7 35
8 89
9 45
10 1
11 50
12 82
13 2
14 1
15 45
16 74
17 141

About K Woelkart

K Woelkart is a scholar working on Complementary and alternative medicine, Immunology and Pharmacology, having authored 17 papers that have together received 873 indexed citations. Recurring topics across this work include Herbal Medicine Research Studies (14 papers), Toxin Mechanisms and Immunotoxins (8 papers) and Complementary and Alternative Medicine Studies (6 papers). The work is most often cited by research in Complementary and alternative medicine (669 citations), Pharmacology (134 citations) and Emergency Medical Services (97 citations). K Woelkart has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Rudolf Bauer, Klaus Linde, J. David Gangemi, Ronald B. Turner, Thomas C. Hulsey, Burkhard Hinz, Bruce Barrett, Dieter Melchart, Egon Marth and Christoph Koidl. Their work appears in journals such as New England Journal of Medicine, Food Chemistry and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026